Navigation Links
Consumer, Business and Labor Groups Endorse Bipartisan Senate Bill Authorizing Biogenerics
Date:3/26/2009

CCPM, AARP, and SEIU Applaud Senators for Introducing Legislation to Reduce Drug Costs for Patients, Expand Market Competition and Choice, and Provide Incentives for Biogeneric Innovation

WASHINGTON, March 26 /PRNewswire-USNewswire/ -- AARP, Coalition for a Competitive Pharmaceutical Market (CCPM), and Service Employees International Union (SEIU) are endorsing the Senate's bipartisan "Promoting Innovation and Access to Life Saving Medicine Act" introduced by Senators Schumer, Brown, Collins, Vitter, Stabenow, Shaheen and Martinez.

This landmark legislation builds on the success of the current Hatch-Waxman law by constraining cost growth, expanding competition and choice and providing needed incentives for innovation. We are pleased that this bill was also introduced by Chairman Waxman and Representatives Deal, Pallone, and Emerson.

"As the nation works to achieve needed reforms in our health care system, it is imperative that patients are able to reap the affordability and access benefit that biogeneric medications provide. The bill introduced today builds on the success of the Hatch-Waxman law and provides the appropriate balance between innovation and access," said CCPM Chair Annette Guarisco, Executive Director, Federal Affairs & Government Compliance, General Motors Corporation.

It is critical for the Senate to pass this legislation in a timely manner to ensure competition in the marketplace and increased access to more affordable biologics. In 2008 healthcare spending increased to $2.4 trillion in the United States; by 2011, biologics spending is likely to exceed $100 million.

"This bill will create a much needed pathway for the approval of affordable and safe biosimilar and interchangeable versions of biologic drugs, and improve the quality of life for millions of Americans. Our over 40 million members over the age of 50 are particularly grateful that this legislation also ensures adequate incentives for research and development of new therapies. This bipartisan bill is a win-win for private and public payers as well as consumers; we commend them for their leadership and their legislation," said AARP Executive Vice President Nancy LeaMond.

"Meaningful healthcare reform requires a mechanism to slow the exponentially increasing price of biologic drugs as more of these products enter the pharmaceutical pipeline. Addressing this issue today will ensure we can provide affordable coverage for the future," said Anthony Barrueta, CCPM Executive Board Member and Vice President, Government Relations for Kaiser Permanente.

"As America finally moves forward on the path to comprehensive healthcare reform, Senators Schumer, Brown, Collins, Vitter, Stabenow, Shaheen, and Martinez are helping pave the way toward constraining prescription drug costs. Working together, with a balanced and bipartisan approach, Congress found a way to make medicine more affordable and accessible to men and women who work for a living," said Andy Stern, President of the SEIU.

All these organizations (and the tens of millions of Americans represented, served or employed) look forward to working with Congress and the Obama Administration to make safe, effective and affordable biogenerics a reality for all consumers. We are thrilled that President Obama included a proposal in his recent budget that mirrors the approach being taken by the legislation we are endorsing today. This bill can and should be a key element of any attempt to constrain health care cost growth and improve overall quality in the health care system.


'/>"/>
SOURCE Coalition for a Competitive Pharmaceutical Market
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Coalition of Consumer, Business, Union and Advocacy Groups Call for Increased Rx Affordability and Accessibility
2. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update
3. tw telecom Extends Portland Area Network Into Tualatin and Lake Oswego Business Districts
4. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
5. Veteran Astronaut Joins Wyle Business Development Staff in Houston
6. Inverness Medical Innovations Agrees to Acquire Second Territory Rapid Diagnostics Business of ACON
7. Frost & Sullivan Recognizes GE Healthcare for Strategic Leadership in Acquiring Dynamic Imaging to Grow Its Imaging Informatics Business
8. American Association for Homecare Applauds President Obamas Plan to Aid Small Businesses
9. Medicines small business practices should be supported by federal budget
10. Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures for Cancer and Other Diseases and Supporting the Economy
11. Business Becomes Affiliate Member of International Trade Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... 27, 2016 , ... In response to meager public awareness, ... of the plight of aphasia. In collaboration with the American Aphasia Association, a ... The link between stroke and aphasia is relatively unknown, but through collaboration with ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Aimed at nurses ... interest stories, which come courtesy of leaders in the nursing and health care industry. ... leading advocates and associations—namely Abilene Christian University. , As the nursing industry is ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: